Delivery Order SPE2DR25D2209-SPE2DR26FD6QM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,554.28. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,595.87 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials. The contract, awarded on November 10, 2025, carries a firm fixed price structure with an ultimate completion date of November 12, 2025. The award represents a competitive procurement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Naloxone 0.4 mg/mL vials valued at $4,056.58 with an ultimate completion date of December 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone 0.4 mg/mL vials under a firm fixed-price contract with a ceiling value of $1,007.56. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains extensive contracts with DLA for...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 4 mg/10 mL vials on July 11, 2025, with a contract ceiling value of $10,276.45. This firm fixed price delivery order, with an ultimate completion date of July 14, 2025, represents a competitively awarded non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Naloxone 2mg/2ml in quantities of 10 units, with a ceiling value of $3,593.26. This is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents performance at the contractor's Conshohocken, Pennsylvania location. This award was not designated as a set-aside contract and was competitively awarded through open competition,...
- The Defense Logistics Agency awarded a $2,311.22 delivery order to AmerisourceBergen Drug Corp for naloxone 0.4 mg/ml vials, with an ultimate completion date of December 23, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes, with a contract value of $1,647.88 and an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract reflects the firm fixed-price delivery order structure typical of the DLA's pharmaceutical procurement approach. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,053.07 and an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6QMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,769.61. This firm fixed-price delivery order, with an ultimate completion date of January 6, 2026, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded to the vendor, demonstrating its capability to meet federal pharmaceutical procurement requirements. This delivery order is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The naloxone supply supports critical medical needs across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/4/26 |